Half Standard Deviation Estimate of the Minimally Important Difference in HRQOL Scores

Published in: Expert Review of Pharmacoeconomics and Outcomes Research, v. 4, no. 5, Oct. 2004, p. 515-523

Posted on RAND.org on January 01, 2004

by Sepideh S. Farivar, Honghu H. Liu, Ron D. Hays

Read More

Access further information on this document at www.future-drugs.com

This article was published outside of RAND. The full text of the article can be found at the link above.

In addition to statistical significance, it is important to evaluate the magnitude of differences in health-related quality of life over time. Interest in establishing the minimal difference that is clinically important or the minimally important difference has burgeoned over the last few years. This review summarizes some of the leading approaches to estimating the minimally important difference, offers caveats on the minimally important difference estimation based on existing literature and provides recommendations for future work. The authors recommend using multiple anchors to estimate the minimally important difference, using only anchors that correspond to minimal change in health-related quality of life, reporting information about the variation around the estimates, and providing bounded estimates to reflect the uncertainty.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.